CG
VTAE

Cutler Group’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Cutler Group’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,100
Closed -$23K – 7989
2016
Q3 		$23K Buy
+1,100
New +$12.7K ﹤0.01% 3306

Cutler Group's VTAE Position: Q4 2016 in Review

Cutler Group sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 1,100 shares — an estimated $23K sold.

Cutler Group first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $23K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • Cutler Group reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • Cutler Group sold 1,100 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $23K.
  • Cutler Group first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
  • Cutler Group's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $23K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Cutler Group's 13F filing for Q4 2016, filed 12 Jan 2017.